Diagnosis and management of post-bariatric surgery hypoglycemia

References

• Aminian A, Zajichek A, Arterburn DE, et al. Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity. JAMA. 2019;322(13):1271–1282. doi: 10.1001/jama.2019.14231
   PubMed Web of Science ®Google Scholar
• Albaugh VL, Kindel TL, Nissen SE, et al. Cardiovascular risk reduction following metabolic and bariatric surgery. Surg Clin North Am. 2021;101(2):269–294. doi:10.1016/j.suc.2020.12.012
   PubMed Web of Science ®Google Scholar
• Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376(7):641–651. doi: 10.1056/NEJMoa1600869
   PubMed Web of Science ®Google Scholar
• Batterham RL, Cummings DE. Mechanisms of diabetes improvement following bariatric/metabolic surgery. Diabetes Care. 2016;39(6):893–901. doi:10.2337/dc16-0145
   PubMed Web of Science ®Google Scholar
• Yang P, Bonham AJ, Ghaferi AA, et al. Comparing diabetes outcomes: weight-independent effects of sleeve gastrectomy versus matched patients with similar weight loss. Ann Surg. 2022;275(5):924–927. doi:10.1097/SLA.0000000000004298
   PubMed Web of Science ®Google Scholar
• Goldfine AB, Mun EC, Devine E, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab. 2007;92(12):4678–4685. doi: 10.1210/jc.2007-0918
   PubMed Web of Science ®Google Scholar
• Manning S, Pucci A, Batterham RL. GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery? Physiology. 2015;30(1):50–62. doi: 10.1152/physiol.00027.2014
   PubMed Web of Science ®Google Scholar
• Guida C, Stephen SD, Watson M, et al. PYY plays a key role in the resolution of diabetes following bariatric surgery in humans. EBioMedicine. 2019;40:67–76. DOI:10.1016/j.ebiom.2018.12.040
   PubMed Web of Science ®Google Scholar
• Marsk R, Jonas E, Rasmussen F, et al. Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden. Diabetologia. 2010;53(11):2307–2311. doi:10.1007/s00125-010-1798-5
   PubMed Web of Science ®Google Scholar
• Sarwar H, Chapman WH 3rd, Pender JR, et al. Hypoglycemia after Roux-en-Y gastric bypass: the BOLD experience. Obes Surg. 2014;24(7):1120–1124. doi: 10.1007/s11695-014-1260-8
   PubMedGoogle Scholar
• Cifuentes L, Hurtado MD, Cortes TM, et al. Evaluation and management of patients referred for post-bariatric surgery hypoglycemia at a tertiary Care center. Obes Surg. 2022;32(5):1578–1585. doi: 10.1007/s11695-022-05986-1
   PubMed Web of Science ®Google Scholar
• Nor Hanipah Z, Punchai S, Birriel TJ, et al. Clinical features of symptomatic hypoglycemia observed after bariatric surgery. Surg Obes Relat Dis. 2018;14(9):1335–1339. doi: 10.1016/j.soard.2018.02.022
   PubMed Web of Science ®Google Scholar
• Tesfaye N, Seaquist E. Neuroendocrine responses to hypoglycemia. Ann N Y Acad Sci. 2010;1212(1):12–28. doi: 10.1111/j.1749-6632.2010.05820.x
   PubMedGoogle Scholar
• Millstein R, Lawler HM. Hypoglycemia after gastric bypass: an emerging complication. Cleve Clin J Med. 2017;84(4):319–328. doi:10.3949/ccjm.84a.16064
   PubMed Web of Science ®Google Scholar
• Mulla CM, Storino A, Yee EU, et al. Insulinoma after bariatric surgery: diagnostic dilemma and therapeutic approaches. Obes Surg. 2016;26(4):874–881. doi: 10.1007/s11695-016-2092-5
   PubMed Web of Science ®Google Scholar
• Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med. 2005;353(3):249–254. doi:10.1056/NEJMoa043690
   PubMed Web of Science ®Google Scholar
• Hui C, Dhakal A, Bauza GJ. Dumping syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. [cited 2023 Jun 26]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470542/
   Google Scholar
• Meier JJ, Butler AE, Galasso R, et al. Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care. 2006;29(7):1554–1559. doi:10.2337/dc06-0392
   PubMed Web of Science ®Google Scholar
• Davis DB, Khoraki J, Ziemelis M, et al. Roux en Y gastric bypass hypoglycemia resolves with gastric feeding or reversal: confirming a non-pancreatic etiology. Mol Metab. 2018;9:15–27. doi:10.1016/j.molmet.2017.12.011
   PubMed Web of Science ®Google Scholar
• Stefater MA, Wilson-Perez HE, Chambers AP, et al. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev. 2012;33(4):595–622. doi:10.1210/er.2011-1044
   PubMed Web of Science ®Google Scholar
• Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240(2):236–242. doi: 10.1097/01.sla.0000133117.12646.48
   PubMed Web of Science ®Google Scholar
• Sista F, Abruzzese V, Clementi M, et al. The effect of sleeve gastrectomy on GLP-1 secretion and gastric emptying: a prospective study. Surg Obes Relat Dis. 2017;13(1):7–14. doi:10.1016/j.soard.2016.08.004
   PubMed Web of Science ®Google Scholar
• Smith EP, Polanco G, Yaqub A, et al. Altered glucose metabolism after bariatric surgery: what’s GLP-1 got to do with it? Metabolism. 2018;83:159–166. doi:10.1016/j.metabol.2017.10.014
   PubMed Web of Science ®Google Scholar
• Shah S, Shah P, Todkar J, et al. Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6(2):152–157. doi:10.1016/j.soard.2009.11.019
   PubMed Web of Science ®Google Scholar
• Braghetto I, Davanzo C, Korn O, et al. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg. 2009;19(11):1515–1521. doi: 10.1007/s11695-009-9954-z
   PubMed Web of Science ®Google Scholar
• Salehi M, Prigeon RL, D’Alessio DA. Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes. 2011;60(9):2308–2314. doi:10.2337/db11-0203
   PubMed Web of Science ®Google Scholar
• Craig CM, Liu LF, Deacon CF, et al. Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia. Diabetologia. 2017;60(3):531–540. doi:10.1007/s00125-016-4179-x
   PubMed Web of Science ®Google Scholar
• Salehi M, Gastaldelli A, D’Alessio DA. Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia. J Clin Endocrinol Metab. 2014;99(6):2008–2017. doi:10.1210/jc.2013-2686
   PubMed Web of Science ®Google Scholar
• Rabiee A, Magruder JT, Salas-Carrillo R, et al. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. J Surg Res. 2011;167(2):199–205. doi: 10.1016/j.jss.2010.09.047
   PubMed Web of Science ®Google Scholar
• Salehi M, Gastaldelli A, DeFronzo R. Prandial hepatic glucose production during hypoglycemia is altered after gastric bypass surgery and sleeve gastrectomy. Metabolism. 2022;131:155199.
   PubMed Web of Science ®Google Scholar
• Tripyla A, Herzig D, Reverter-Branchat G, et al. Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals. Diabetologia. 2023;66(4):741–753. doi: 10.1007/s00125-022-05861-9
   PubMed Web of Science ®Google Scholar
• de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17(5):657–669. doi:10.1016/j.cmet.2013.03.013
   PubMed Web of Science ®Google Scholar
• Albaugh VL, Banan B, Ajouz H, et al. Bile acids and bariatric surgery. Mol Aspects Med. 2017;56:75–89. doi:10.1016/j.mam.2017.04.001
   PubMed Web of Science ®Google Scholar
• Albaugh VL, Banan B, Antoun J, et al. Role of bile acids and GLP-1 in mediating the metabolic improvements of bariatric surgery. Gastroenterology. 2019;156(4):1041–1051. doi: 10.1053/j.gastro.2018.11.017
   PubMed Web of Science ®Google Scholar
• van Furth AM, van den Broek M, Emous M, et al. Cholecystectomy increases the risk of dumping syndrome and postbariatric hypoglycemia after bariatric surgery. Surg Obes Relat Dis. 2020;16(12):1939–1947. doi:10.1016/j.soard.2020.08.009
   PubMed Web of Science ®Google Scholar
• Zhou LY, Deng MQ, Xiao XH. Potential contribution of the gut microbiota to hypoglycemia after gastric bypass surgery. Chin Med J (Engl). 2020;133(15):1834–1843. doi:10.1097/CM9.0000000000000932
   PubMed Web of Science ®Google Scholar
• Benedix F, Westphal S, Patschke R, et al. Weight loss and changes in salivary ghrelin and adiponectin: comparison between sleeve gastrectomy and Roux-en-Y gastric bypass and gastric banding. Obes Surg. 2011;21(5):616–624. doi: 10.1007/s11695-011-0374-5
   PubMed Web of Science ®Google Scholar
• Beckman LM, Beckman TR, Sibley SD, et al. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. JPEN J Parenter Enteral Nutr. 2011;35(2):169–180. doi: 10.1177/0148607110381403
   PubMed Web of Science ®Google Scholar
• Salehi M, Vella A, McLaughlin T, et al. Hypoglycemia after gastric bypass surgery: current concepts and controversies. J Clin Endocrinol Metab. 2018;103(8):2815–2826. doi:10.1210/jc.2018-00528
   PubMed Web of Science ®Google Scholar
• Halperin F, Patti ME, Skow M, et al. Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass. J Obes. 2011;2011:869536. doi: 10.1155/2011/869536
   PubMedGoogle Scholar
• Kellogg TA, Bantle JP, Leslie DB, et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis. 2008;4(4):492–499. doi: 10.1016/j.soard.2008.05.005
   PubMed Web of Science ®Google Scholar
• Valderas JP, Ahuad J, Rubio L, et al. Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels. Obes Surg. 2012;22(4):582–586. doi:10.1007/s11695-011-0581-0
   PubMed Web of Science ®Google Scholar
• Mulla CM, Storino A, Yee EU, et al. Insulinoma after bariatric surgery: diagnostic dilemma and therapeutic approaches. Obes Surg. 2016;26(4):874–881. doi:10.1007/s11695-016-2092-5
   PubMed Web of Science ®Google Scholar
• Boettcher C, Dost A, Wudy SA, et al. Accuracy of blood glucose meters for self-monitoring affects glucose control and hypoglycemia rate in children and adolescents with type 1 diabetes. Diabetes Technol Ther. 2015;17(4):275–282. doi: 10.1089/dia.2014.0262
   PubMed Web of Science ®Google Scholar
• Lev-Ran A, Anderson RW. The diagnosis of postprandial hypoglycemia. Diabetes. 1981;30(12):996–999. doi:10.2337/diab.30.12.996
   PubMed Web of Science ®Google Scholar
• Sheehan E, Patti ME. Hypoglycemia after upper gastrointestinal surgery: clinical approach to assessment, diagnosis, and treatment. Diabetes Metab Syndr Obes. 2020;13:4469–4482.
   PubMed Web of Science ®Google Scholar
• Eisenberg D, Azagury DE, Ghiassi S, et al. ASMBS position statement on postprandial hyperinsulinemic hypoglycemia after bariatric surgery. Surg Obes Relat Dis. 2017;13(3):371–378. doi:10.1016/j.soard.2016.12.005
   PubMed Web of Science ®Google Scholar
• Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(3):709–728. doi: 10.1210/jc.2008-1410
   PubMed Web of Science ®Google Scholar
• Bantle AE, Wang Q, Bantle JP. Post-gastric bypass hyperinsulinemic hypoglycemia: fructose is a carbohydrate which can be safely consumed. J Clin Endocrinol Metab. 2015;100(8):3097–3102. doi:10.1210/jc.2015-1283
   PubMed Web of Science ®Google Scholar
• Isom KA. Standardizing the evolution of the postoperative bariatric diet. Diabetes Spectr. 2012;25(4):222–228. doi:10.2337/diaspect.25.4.222
   Google Scholar
• Bantle JP, Ikramuddin S, Kellogg TA, et al. Hyperinsulinemic hypoglycemia developing late after gastric bypass. Obes Surg. 2007;17(5):592–594. doi:10.1007/s11695-007-9102-6
   PubMed Web of Science ®Google Scholar
• Botros N, Rijnaarts I, Brandts H, et al. Effect of carbohydrate restriction in patients with hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. Obes Surg. 2014;24(11):1850–1855. doi:10.1007/s11695-014-1319-6
   PubMed Web of Science ®Google Scholar
• Ritz P, Vaurs C, Bertrand M, et al. Usefulness of acarbose and dietary modifications to limit glycemic variability following Roux-en-Y gastric bypass as assessed by continuous glucose monitoring. Diabetes Technol Ther. 2012;14(8):736–740. doi:10.1089/dia.2011.0302
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gonzalez A, Delgado M, Fraga-Fuentes MD. Use of diazoxide in management of severe postprandial hypoglycemia in patient after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2013;9(1):e18–9. doi:10.1016/j.soard.2011.05.010
   PubMedGoogle Scholar
• Spanakis E, Gragnoli C. Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia. Obes Surg. 2009;19(9):1333–1334. doi:10.1007/s11695-009-9888-5
   PubMed Web of Science ®Google Scholar
• Vilarrasa N, Goday A, Rubio MA, et al. Hyperinsulinemic hypoglycemia after bariatric surgery: diagnosis and management experience from a Spanish multicenter registry. Obes Facts. 2016;9(1):41–51. doi: 10.1159/000442764
   PubMed Web of Science ®Google Scholar
• Myint KS, Greenfield JR, Farooqi IS, et al. Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: the pathophysiological role of GLP1 and its response to a somatostatin analogue. Eur J Endocrinol. 2012;166(5):951–955. doi:10.1530/EJE-11-1065
   PubMed Web of Science ®Google Scholar
• Ohrstrom CC, Worm D, Hojager A, et al. Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide. Diab Obes Metab. 2019;21(9):2142–2151. doi: 10.1111/dom.13796
   PubMed Web of Science ®Google Scholar
• Malik S, Mitchell JE, Steffen K, et al. Recognition and management of hyperinsulinemic hypoglycemia after bariatric surgery. Obes Res Clin Pract. 2016;10(1):1–14. doi: 10.1016/j.orcp.2015.07.003
   PubMed Web of Science ®Google Scholar
• Ames A, Lago-Hernandez CA, Grunvald E. Hypoglycemia after gastric bypass successfully treated with Calcium channel blockers: two case reports. J Endocr Soc. 2019;3(7):1417–1422. doi:10.1210/js.2019-00097
   PubMed Web of Science ®Google Scholar
• Abrahamsson N, Engstrom BE, Sundbom M, et al. GLP1 analogs as treatment of postprandial hypoglycemia following gastric bypass surgery: a potential new indication? Eur J Endocrinol. 2013;169(6):885–889. doi:10.1530/EJE-13-0504
   PubMed Web of Science ®Google Scholar
• Chiappetta S, Stier C. A case report: liraglutide as a novel treatment option in late dumping syndrome. Medicine (Baltimore). 2017;96(12):e6348. doi:10.1097/MD.0000000000006348
   PubMed Web of Science ®Google Scholar
• Tan M, Lamendola C, Luong R, et al. Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9-39) for treatment of post-bariatric hypoglycaemia. Diab Obes Metab. 2020;22(8):1406–1416. doi:10.1111/dom.14048
   PubMed Web of Science ®Google Scholar
• Craig CM, Liu LF, Nguyen T, et al. Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemia. Diab Obes Metab. 2018;20(2):352–361. doi:10.1111/dom.13078
   PubMed Web of Science ®Google Scholar
• Craig CM, Lawler HM, Lee CJE, et al. PREVENT: a randomized, placebo-controlled crossover trial of avexitide for treatment of postbariatric hypoglycemia. J Clin Endocrinol Metab 13. 2021;106(8):e3235–e48. doi: 10.1210/clinem/dgab103
   PubMed Web of Science ®Google Scholar
• Nielsen CK, Øhrstrøm CC, Kielgast UL, et al. Dasiglucagon effectively mitigates postbariatric postprandial hypoglycemia: a randomized, Double-blind, placebo-controlled, crossover trial. Diabetes Care. 2022;45(6):1476–1481. doi: 10.2337/dc21-2252
   PubMed Web of Science ®Google Scholar
• Johnson KW, Neale A, Gordon A, et al. Attenuation of insulin action by an allosteric insulin receptor antibody in healthy volunteers. J Clin Endocrinol Metab. 2017;102(8):3021–3028. doi: 10.1210/jc.2017-00822
   PubMed Web of Science ®Google Scholar
• Mulla CM, Zavitsanou S, Laguna Sanz AJ, et al. A randomized, placebo-controlled double-blind trial of a closed-loop glucagon system for postbariatric hypoglycemia. J Clin Endocrinol Metab. 2020;105(4):e1260–e1271. doi: 10.1210/clinem/dgz197
   PubMed Web of Science ®Google Scholar
• Carpentieri GB, Gonçalves SEAB, Casagrande MZ, et al. SGLT2 inhibition with Empagliflozin as a possible therapeutic option for postprandial hypoglycemia after bariatric surgery. Obes Surg. 2022;32(8):2664–2671. doi: 10.1007/s11695-022-06119-4
   PubMed Web of Science ®Google Scholar
• Mala T. Postprandial hyperinsulinemic hypoglycemia after gastric bypass surgical treatment. Surg Obes Relat Dis. 2014;10(6):1220–1225. doi:10.1016/j.soard.2014.01.010
   PubMed Web of Science ®Google Scholar
• Z’Graggen K, Guweidhi A, Steffen R, et al. Severe recurrent hypoglycemia after gastric bypass surgery. Obes Surg. 2008;18(8):981–988. doi: 10.1007/s11695-008-9480-4
   PubMed Web of Science ®Google Scholar
• Zanley E, Shah ND, Craig C, et al. Guidelines for gastrostomy tube placement and enteral nutrition in patients with severe, refractory hypoglycemia after gastric bypass. Surg Obes Relat Dis. 2021;17(2):456–465. doi:10.1016/j.soard.2020.09.026
   PubMed Web of Science ®Google Scholar
• Shoar S, Nguyen T, Ona MA, et al. Roux-en-Y gastric bypass reversal: a systematic review. Surg Obes Relat Dis. 2016;12(7):1366–1372. doi: 10.1016/j.soard.2016.02.023
   PubMed Web of Science ®Google Scholar
• Aminian A, Brethauer SA, Parekh N, et al. Metabolic consequences of restorative surgery after gastric bypass. Diabetes Care. 2017;40(4):e42–e3. doi:10.2337/dc16-2561
   PubMed Web of Science ®Google Scholar
• Xu Q, Zou X, You L, et al. Surgical treatment for postprandial hypoglycemia after Roux-en-Y gastric bypass: a literature review. Obes Surg. 2021;31(4):1801–1809. doi: 10.1007/s11695-021-05251-x
   PubMed Web of Science ®Google Scholar
• Clancy TE, Moore FD Jr., Zinner MJ. Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. J Gastrointest Surg. 2006;10(8):1116–1119. doi:10.1016/j.gassur.2006.04.008
   PubMed Web of Science ®Google Scholar
• Vanderveen KA, Grant CS, Thompson GB, et al. Outcomes and quality of life after partial pancreatectomy for noninsulinoma pancreatogenous hypoglycemia from diffuse islet cell disease. Surgery. 2010;148(6):1237–1245. discussion 1245-6. doi: 10.1016/j.surg.2010.09.027
   PubMed Web of Science ®Google Scholar
• Michaels AD, Mehaffey JH, French WB, et al. Hypoglycemia following bariatric surgery: our 31-year experience. Obes Surg. 2017;27(12):3118–3123. doi:10.1007/s11695-017-2734-2
   PubMed Web of Science ®Google Scholar